fingolimod hydrochloride has been researched along with Acute Disease in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 6 (42.86) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Dahlke, F; Häring, DA; Kappos, L; Kropshofer, H; Kuhle, J; Leppert, D; Meinert, R; Patil, A; Tomic, D | 1 |
| Hirt, SW; Lehle, K; Puehler, T; Schmid, C; von Suesskind-Schwendi, M | 1 |
| Gao, M; Kayoumu, A; Liu, G; Liu, J; Wang, M; Wang, Y; Xu, P; Zhang, L; Zhang, X | 1 |
| Matsui, M | 1 |
| Belyaev, O; Bergmann, U; Burr, W; McArthur, N; Müller, CA; Munding, J; Tannapfel, A; Uhl, W; Werner, J | 1 |
| Hogan, WJ; Kuhr, CS; Lee, RS; Little, MT; Sale, GE; Storb, R; Zellmer, E | 1 |
| Baumann, DR; Cannet, C; Foster, CA; Hiestand, P; Rausch, M; Rudin, M | 1 |
| He, JH; Lin, ZB; Zhang, HN | 1 |
| Ito, T; Matsuda, C; Matsuda, H; Miao, G; Nishida, T; Nozawa, M; Sawa, Y; Song, J; Tanemura, M | 1 |
| Fukao, K; Jinzenji, Y; Otsuka, M; Sakurayama, N; Suzuki, S; Takada, Y; Taniguchi, H; Yuzawa, K | 1 |
| Chueh, SC; Clark, J; Kahan, BD; Qu, X; Stepkowski, SM; Troncoso, P; Wang, ME | 1 |
| Kahan, BD | 1 |
| Chiba, K; Kobayakawa, T | 1 |
| Hwang, MW; Ito, H; Matsumori, A; Miyamoto, T; Nishio, R; Sasayama, S | 1 |
2 review(s) available for fingolimod hydrochloride and Acute Disease
| Article | Year |
|---|---|
The potential role of rapamycin in pediatric transplantation as observed from adult studies.
Topics: Acute Disease; Adult; Age Factors; Antibodies, Monoclonal; Basiliximab; Child; Cohort Studies; Cyclosporine; Drug Monitoring; Fingolimod Hydrochloride; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Propylene Glycols; Protein-Tyrosine Kinases; Recombinant Fusion Proteins; Sirolimus; Sphingosine; Time Factors; Tyrphostins | 1999 |
[Immunosuppressive agent FTY720].
Topics: Acute Disease; Animals; Autoimmune Diseases; Cyclosporine; Drug Design; Drug Therapy, Combination; Fingolimod Hydrochloride; Graft Rejection; Humans; Immunosuppressive Agents; Propylene Glycols; Sphingosine; Transplantation, Homologous | 2000 |
1 trial(s) available for fingolimod hydrochloride and Acute Disease
| Article | Year |
|---|---|
The potential role of rapamycin in pediatric transplantation as observed from adult studies.
Topics: Acute Disease; Adult; Age Factors; Antibodies, Monoclonal; Basiliximab; Child; Cohort Studies; Cyclosporine; Drug Monitoring; Fingolimod Hydrochloride; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Propylene Glycols; Protein-Tyrosine Kinases; Recombinant Fusion Proteins; Sirolimus; Sphingosine; Time Factors; Tyrphostins | 1999 |
12 other study(ies) available for fingolimod hydrochloride and Acute Disease
| Article | Year |
|---|---|
Blood Neurofilament Light in Progressive Multiple Sclerosis: Post Hoc Analysis of 2 Randomized Controlled Trials.
Topics: Acute Disease; Atrophy; Biomarkers; Disease Progression; Fingolimod Hydrochloride; Humans; Intermediate Filaments; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Randomized Controlled Trials as Topic | 2022 |
Early administration of FTY720 prevents chronic airway as well as vascular destruction in experimental rat lung transplantation.
Topics: Acute Disease; Animals; Bronchiolitis Obliterans; Chronic Disease; Drug Administration Schedule; Fingolimod Hydrochloride; Graft Rejection; Immunosuppressive Agents; Lung; Lung Transplantation; Lymphocytes; Male; Propylene Glycols; Rats; Rats, Inbred F344; Rats, Inbred WKY; Sclerosis; Sphingosine; Time Factors; Vascular Diseases | 2013 |
FTY720 Attenuates Acute Pancreatitis in Hypertriglyceridemic Apolipoprotein CIII Transgenic Mice.
Topics: Acute Disease; Amylases; Animals; Apolipoprotein C-III; Ceruletide; Chemokine CCL2; Drug Evaluation, Preclinical; Female; Fingolimod Hydrochloride; Hypertriglyceridemia; Immunosuppressive Agents; Lymphocyte Count; Mice, Transgenic; Pancreas; Pancreatitis | 2015 |
[How to use Japanese guidelines for the treatment of multiple sclerosis].
Topics: Acute Disease; Asian People; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Multiple Sclerosis; Practice Guidelines as Topic; Recurrence | 2015 |
Effects of FTY720 and rapamycin on inflammation in taurocholate-induced acute pancreatitis in the rat.
Topics: Acute Disease; Amylases; Animals; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Female; Fingolimod Hydrochloride; Hydrocortisone; Immunosuppressive Agents; Interleukin-10; Interleukin-6; Pancreas; Pancreatitis; Propylene Glycols; Rats; Rats, Wistar; Sirolimus; Sphingosine; T-Lymphocytes; Taurocholic Acid | 2012 |
FTY720 does not abrogate acute graft-versus-host disease in the dog leukocyte antigen-nonidentical unrelated canine model.
Topics: Acute Disease; Animals; Dogs; Fingolimod Hydrochloride; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility; Immunosuppressive Agents; Lymphocyte Count; Propylene Glycols; Recurrence; Severity of Illness Index; Sphingosine | 2003 |
Predictability of FTY720 efficacy in experimental autoimmune encephalomyelitis by in vivo macrophage tracking: clinical implications for ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging.
Topics: Acute Disease; Animals; Blood-Brain Barrier; Brain; Contrast Media; Dextrans; Encephalomyelitis, Autoimmune, Experimental; Female; Ferrosoferric Oxide; Fingolimod Hydrochloride; Heterocyclic Compounds; Immunohistochemistry; Immunosuppressive Agents; Iron; Macrophages; Magnetic Resonance Imaging; Magnetite Nanoparticles; Organometallic Compounds; Oxides; Propylene Glycols; Rats; Rats, Inbred Lew; Receptors, G-Protein-Coupled; Receptors, Lysophospholipid; Recurrence; Sphingosine | 2004 |
Effect of 2-amino-2-(2-(4-octylphenyl) ethyl) propane-1,3-diol hydrochloride (FTY 720) on immune liver injury in mice.
Topics: Acute Disease; Alanine Transaminase; Animals; Apoptosis; Aspartate Aminotransferases; Cell Division; Concanavalin A; Fingolimod Hydrochloride; Hepatocytes; Immunosuppressive Agents; Interferon-gamma; Interleukin-4; Lipopolysaccharides; Liver Diseases; Male; Mice; Mycobacterium bovis; Propylene Glycols; Rats; Rats, Wistar; Sphingosine; Spleen | 2005 |
Inhibition of donor-derived T cells trafficking into target organs by FTY720 during acute graft-versus-host disease in small bowel transplantation.
Topics: Acute Disease; Animals; Body Weight; Cytokines; Fingolimod Hydrochloride; Graft vs Host Disease; Immunosuppressive Agents; Intestine, Small; Liver; Lymphocyte Count; Male; Propylene Glycols; Rats; Rats, Inbred WF; Skin; Sphingosine; T-Lymphocyte Subsets; Transplantation Chimera | 2006 |
An effect of FTY720 on acute rejection in canine renal transplantation.
Topics: Acute Disease; Animals; Blood Cell Count; Cyclosporine; Dogs; Fingolimod Hydrochloride; Graft Rejection; Graft Survival; Immunosuppressive Agents; Kidney Transplantation; Lymphocyte Count; Propylene Glycols; Sphingosine; Transplantation, Homologous | 1998 |
Prophylaxis of acute renal allograft rejection using FTY720 in combination with subtherapeutic doses of cyclosporine.
Topics: Acute Disease; Animals; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fingolimod Hydrochloride; Graft Rejection; Immunosuppressive Agents; Kidney Transplantation; Macaca fascicularis; Propylene Glycols; Sphingosine; Transplantation, Homologous | 1999 |
Therapeutic effects of FTY720, a new immunosuppressive agent, in a murine model of acute viral myocarditis.
Topics: Acute Disease; Animals; Cardiovirus Infections; Disease Models, Animal; Drug Evaluation, Preclinical; Encephalomyocarditis virus; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Interferon-gamma; Interleukin-12; Interleukin-2; Male; Mice; Mice, Inbred DBA; Myocarditis; Nitric Oxide; Proportional Hazards Models; Propylene Glycols; Severity of Illness Index; Sphingosine; Survival Analysis; Treatment Outcome; Tumor Necrosis Factor-alpha | 2001 |